
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 10, 2025, titled "Glenmark Therapeutics Inc., USA launches Polyethylene Glycol 3350, Powder for Solution, 17grams/capful (OTC)".
Filed with NSE ·

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 10, 2025, titled "Glenmark Therapeutics Inc., USA launches Polyethylene Glycol 3350, Powder for Solution, 17grams/capful (OTC)".
6ix hasn’t read this filing yet.
Glenmark Pharmaceuticals Limited on 6ix
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals